about
Sunitinib in combination with gemcitabine for advanced solid tumours: a phase I dose-finding study.Targeted drug delivery in pancreatic cancerNovel role of VMP1 as modifier of the pancreatic tumor cell response to chemotherapeutic drugs.Current status of molecular markers for early detection of sporadic pancreatic cancer.Redox-responsive targeted gelatin nanoparticles for delivery of combination wt-p53 expressing plasmid DNA and gemcitabine in the treatment of pancreatic cancer.The oncogenic receptor ErbB2 modulates gemcitabine and irinotecan/SN-38 chemoresistance of human pancreatic cancer cells via hCNT1 transporter and multidrug-resistance associated protein MRP-2.Downregulation of ASPP2 in pancreatic cancer cells contributes to increased resistance to gemcitabine through autophagy activation.MicroRNA-100 and microRNA-21 as markers of survival and chemotherapy response in pancreatic ductal adenocarcinoma UICC stage II.The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the Concentrative Nucleoside Transporter family.Complete Response after Treatment with Neoadjuvant Chemoradiation with Prolonged Chemotherapy for Locally Advanced, Unresectable Adenocarcinoma of the Pancreas.Gemcitabine combined with gum mastic causes potent growth inhibition and apoptosis of pancreatic cancer cells.Interdependence of gemcitabine treatment, transporter expression, and resistance in human pancreatic carcinoma cells.Irinotecan synergistically enhances the antiproliferative and proapoptotic effects of axitinib in vitro and improves its anticancer activity in vivo.
P2860
Q33406542-3374058D-0DAE-4019-8D3F-898310372557Q33625651-4FED8633-7342-4858-9BC3-7CB7552854FFQ33720758-582DD9D6-6737-4540-9B5E-85EEFF859F3EQ34458903-96FED3E4-619F-45A3-ADEA-61E1EAF8DC9DQ35089242-10180DC1-B480-418B-ADD2-3067E4EC1A78Q35793641-EC2A85EE-8F6A-40B6-B163-8D7F9EA7BA07Q36126145-A535E7DB-8B71-42CF-8B6E-BCD79963C6E3Q36401986-A2E799F7-8AD8-4BD8-88D4-71FE879841BFQ37605606-1A1C5C93-5AE5-4C2D-B8A6-1DE918775FA1Q37714700-C80C63A3-D530-4AB1-A409-B333B84B2CAAQ39022283-331A2955-AC8A-446E-8D64-E840FF6DE9EAQ39658359-D957C10F-230C-4DDF-A624-C42A2E2F4BF5Q41872813-AB5DF0F0-9707-4C92-88B1-A13FF3D66AE6
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pancreatic adenocarcinoma: new strategies for success
@en
Pancreatic adenocarcinoma: new strategies for success.
@nl
type
label
Pancreatic adenocarcinoma: new strategies for success
@en
Pancreatic adenocarcinoma: new strategies for success.
@nl
prefLabel
Pancreatic adenocarcinoma: new strategies for success
@en
Pancreatic adenocarcinoma: new strategies for success.
@nl
P2860
P1476
Pancreatic adenocarcinoma: new strategies for success
@en
P2093
Eileen M O'Reilly
P2860
P433
P577
2009-03-01T00:00:00Z